Eiry Roberts - 07 Dec 2023 Form 4 Insider Report for NEUROCRINE BIOSCIENCES INC (NBIX)

Reporting relationship: Chief Medical Officer
Issuer ticker: NBIX
Reported as of: 07 Dec 2023
Net transaction value: -$9,350,350
SEC form: 4
Accepted by SEC: 11 Dec 2023, 18:18:39 UTC
Prior SEC filing: 08 Dec 2023
Next SEC filing: 14 Dec 2023
Source filing: View source filing
Reporting owner signature: /s/ Darin Lippoldt, Attorney-in-Fact

Key filing fact

Eiry Roberts filed Form 4 for NEUROCRINE BIOSCIENCES INC (NBIX) on 11 Dec 2023.

Key facts

This page summarizes Eiry Roberts's Form 4 filing for NEUROCRINE BIOSCIENCES INC (NBIX).
18 reported transactions and 6 derivative rows are listed below.
Accepted by SEC: 11 Dec 2023, 18:18.

Change

Previous filing in this sequence was filed on 08 Dec 2023.
Current net transaction value: -$9,350,350.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NBIX transaction

Common Stock

Options Exercise

Transaction value: $3,012,959
Shares: +38,722
Change %: +131%
Price: $77.81
Shares after: 68,243
Date: 07 Dec 2023
Ownership: Direct

NBIX transaction

Common Stock

Sale

Transaction value: $4,661,118
Shares: -38,722
Change %: -57%
Price: $120.37
Shares after: 29,521
Date: 07 Dec 2023
Ownership: Direct
Footnotes: F1, F2

NBIX transaction

Common Stock

Options Exercise

Transaction value: $991,455
Shares: +12,742
Change %: +43%
Price: $77.81
Shares after: 42,263
Date: 07 Dec 2023
Ownership: Direct

NBIX transaction

Common Stock

Sale

Transaction value: $1,533,774
Shares: -12,742
Change %: -30%
Price: $120.37
Shares after: 29,521
Date: 07 Dec 2023
Ownership: Direct
Footnotes: F1, F3

NBIX transaction

Common Stock

Options Exercise

Transaction value: $1,117,343
Shares: +14,140
Change %: +48%
Price: $79.02
Shares after: 43,661
Date: 07 Dec 2023
Ownership: Direct

NBIX transaction

Common Stock

Sale

Transaction value: $1,702,053
Shares: -14,140
Change %: -32%
Price: $120.37
Shares after: 29,521
Date: 07 Dec 2023
Ownership: Direct
Footnotes: F1, F3

NBIX transaction

Common Stock

Options Exercise

Transaction value: $954,364
Shares: +11,775
Change %: +40%
Price: $81.05
Shares after: 41,296
Date: 07 Dec 2023
Ownership: Direct

NBIX transaction

Common Stock

Sale

Transaction value: $1,417,374
Shares: -11,775
Change %: -29%
Price: $120.37
Shares after: 29,521
Date: 07 Dec 2023
Ownership: Direct
Footnotes: F1, F3

NBIX transaction

Common Stock

Options Exercise

Transaction value: $16,210
Shares: +200
Change %: +0.68%
Price: $81.05
Shares after: 29,721
Date: 08 Dec 2023
Ownership: Direct

NBIX transaction

Common Stock

Sale

Transaction value: $24,031
Shares: -200
Change %: -0.67%
Price: $120.16
Shares after: 29,521
Date: 08 Dec 2023
Ownership: Direct
Footnotes: F1, F4

NBIX transaction

Common Stock

Options Exercise

Transaction value: $8,105
Shares: +100
Change %: +0.34%
Price: $81.05
Shares after: 29,621
Date: 08 Dec 2023
Ownership: Direct

NBIX transaction

Common Stock

Sale

Transaction value: $12,000
Shares: -100
Change %: -0.34%
Price: $120.00
Shares after: 29,521
Date: 08 Dec 2023
Ownership: Direct
Footnotes: F1, F5

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NBIX transaction Derivative

Non-Qualified Stock Option

Options Exercise

Transaction value: $3,012,959
Shares: -38,722
Change %: -75%
Price: $77.81
Shares after: 12,742
Date: 07 Dec 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 38,722
Exercise price: $77.81
Footnotes: F6

NBIX transaction Derivative

Non-Qualified Stock Option

Options Exercise

Transaction value: $991,455
Shares: -12,742
Change %: -100%
Price: $77.81
Shares after: 0
Date: 07 Dec 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 12,742
Exercise price: $77.81
Footnotes: F6

NBIX transaction Derivative

Non-Qualified Stock Option

Options Exercise

Transaction value: $1,117,343
Shares: -14,140
Change %: -19%
Price: $79.02
Shares after: 60,005
Date: 07 Dec 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 14,140
Exercise price: $79.02
Footnotes: F7

NBIX transaction Derivative

Non-Qualified Stock Option

Options Exercise

Transaction value: $954,364
Shares: -11,775
Change %: -18%
Price: $81.05
Shares after: 53,665
Date: 07 Dec 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 11,775
Exercise price: $81.05
Footnotes: F8

NBIX transaction Derivative

Non-Qualified Stock Option

Options Exercise

Transaction value: $16,210
Shares: -200
Change %: -0.37%
Price: $81.05
Shares after: 53,465
Date: 08 Dec 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 200
Exercise price: $81.05
Footnotes: F8

NBIX transaction Derivative

Non-Qualified Stock Option

Options Exercise

Transaction value: $8,105
Shares: -100
Change %: -0.19%
Price: $81.05
Shares after: 53,365
Date: 08 Dec 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 100
Exercise price: $81.05
Footnotes: F8

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 8 footnotes

Footnote F1

The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on November 11, 2022. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan.

Footnote F2

Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $120.00 to $121.18. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Footnote F3

Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $120.00 to $121.25. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Footnote F4

Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $120.00 to $120.31. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Footnote F5

28,366 of the outstanding shares are held by The Stephen Tayor and Eiry W. Roberts Joint Trust Agreement, of which Dr. Roberts has voting and investment power.

Footnote F6

Option granted January 8, 2018 and vests at 25% upon first anniversary (January 8, 2019) and remaining 75% vesting in 36 equal monthly installments beginning February 8, 2019.

Footnote F7

Option granted January 31, 2022 and vested monthly over four years.

Footnote F8

Option granted February 7, 2019 and vested monthly over four years.